Mosholder AD - Search Results

1

Overall and cause-specific mortality in the Sentinel system: A power analysis.

Swain RS, Taylor LG, Woodworth TS, Fuller CC, Petrone AB, Menzin TJ, Haug NR, Toh S, Mosholder AD. Swain RS, et al. Among authors: mosholder ad. Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1416-1421. doi: 10.1002/pds.4692. Epub 2018 Nov 13. Pharmacoepidemiol Drug Saf. 2018. PMID: 30421839

2

An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system.

Colman E, Szarfman A, Wyeth J, Mosholder A, Jillapalli D, Levine J, Avigan M. Colman E, et al. Pharmacoepidemiol Drug Saf. 2008 Nov;17(11):1068-76. doi: 10.1002/pds.1643. Pharmacoepidemiol Drug Saf. 2008. PMID: 18821724

3

Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors.

Rowan C, Brinker AD, Nourjah P, Chang J, Mosholder A, Barrett JS, Avigan M. Rowan C, et al. Among authors: mosholder a. Pharmacoepidemiol Drug Saf. 2009 Apr;18(4):301-9. doi: 10.1002/pds.1711. Pharmacoepidemiol Drug Saf. 2009. PMID: 19206087 Free PMC article.

4

Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions.

Pamer CA, Hammad TA, Wu YT, Kaplan S, Rochester G, Governale L, Mosholder AD. Pamer CA, et al. Among authors: mosholder ad. Pharmacoepidemiol Drug Saf. 2010 Feb;19(2):158-74. doi: 10.1002/pds.1886. Pharmacoepidemiol Drug Saf. 2010. PMID: 20049836

5

Neuropsychiatric events in varenicline and nicotine replacement patch users in the Military Health System.

Meyer TE, Taylor LG, Xie S, Graham DJ, Mosholder AD, Williams JR, Moeny D, Ouellet-Hellstrom RP, Coster TS. Meyer TE, et al. Among authors: mosholder ad. Addiction. 2013 Jan;108(1):203-10. doi: 10.1111/j.1360-0443.2012.04024.x. Epub 2012 Oct 18. Addiction. 2013. PMID: 22812921

6

Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study.

Graham DJ, By K, McKean S, Mosholder A, Kornegay C, Racoosin JA, Young J, Levenson M, MaCurdy TE, Worrall C, Kelman JA. Graham DJ, et al. Pharmacoepidemiol Drug Saf. 2014 Nov;23(11):1205-12. doi: 10.1002/pds.3678. Epub 2014 Jul 5. Pharmacoepidemiol Drug Saf. 2014. PMID: 25044169

7

Reservations about study on antidepressant use by young people and suicidal behaviour after FDA warnings.

Mosholder AD, Taylor LG, Crentsil V. Mosholder AD, et al. BMJ. 2014 Oct 29;349:g6503. doi: 10.1136/bmj.g6503. BMJ. 2014. PMID: 25355684 No abstract available.

8

Incidence of Heart Failure and Cardiomyopathy Following Initiation of Medications for Attention-Deficit/Hyperactivity Disorder: A Descriptive Study.

Mosholder AD, Taylor L, Mannheim G, Ortendahl L, Woodworth TS, Toh S. Mosholder AD, et al. J Clin Psychopharmacol. 2018 Oct;38(5):505-508. doi: 10.1097/JCP.0000000000000939. J Clin Psychopharmacol. 2018. PMID: 30102629

9

Comment on: "Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs".

Suggs CM, Levin RL, Mosholder AD, Swain RS, Zhao L. Suggs CM, et al. Among authors: mosholder ad. Drug Saf. 2018 Dec;41(12):1419-1421. doi: 10.1007/s40264-018-0726-3. Drug Saf. 2018. PMID: 30232739 No abstract available.

10

A systematic review of validated suicide outcome classification in observational studies.

Swain RS, Taylor LG, Braver ER, Liu W, Pinheiro SP, Mosholder AD. Swain RS, et al. Among authors: mosholder ad. Int J Epidemiol. 2019 Oct 1;48(5):1636-1649. doi: 10.1093/ije/dyz038. Int J Epidemiol. 2019. PMID: 30907424

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters